share_log

Craig-Hallum Maintains Buy on Avid Bioservices, Lowers Price Target to $16

Craig-Hallum Maintains Buy on Avid Bioservices, Lowers Price Target to $16

Craig-Hallum 维持对Avid Bioservices的买入,将目标股价下调至16美元
Benzinga ·  2023/12/08 12:11

Craig-Hallum analyst Matt Hewitt maintains Avid Bioservices (NASDAQ:CDMO) with a Buy and lowers the price target from $22 to $16.

Craig-Hallum分析师马特·休伊特维持Avid Bioservices(纳斯达克股票代码:CDMO)的买入,并将目标股价从22美元下调至16美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发